Pfizer quits Duchenne gene therapy, lays off staff following study setback
BioPharma Drive: Drug Pricing
JULY 30, 2024
The company is letting go of 150 staffers alongside a decision to officially terminate the high-profile program, which was acquired in 2016.
Let's personalize your content